Cargando…

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist

How the brain dynamics change during anesthetic-induced altered states of consciousness is not completely understood. The α2-adrenergic agonists are unique. They generate unconsciousness selectively through α2-adrenergic receptors and related circuits. We studied intracortical neuronal dynamics duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballesteros, Jesus Javier, Briscoe, Jessica Blair, Ishizawa, Yumiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455241/
https://www.ncbi.nlm.nih.gov/pubmed/32857037
http://dx.doi.org/10.7554/eLife.57670
_version_ 1783575591820197888
author Ballesteros, Jesus Javier
Briscoe, Jessica Blair
Ishizawa, Yumiko
author_facet Ballesteros, Jesus Javier
Briscoe, Jessica Blair
Ishizawa, Yumiko
author_sort Ballesteros, Jesus Javier
collection PubMed
description How the brain dynamics change during anesthetic-induced altered states of consciousness is not completely understood. The α2-adrenergic agonists are unique. They generate unconsciousness selectively through α2-adrenergic receptors and related circuits. We studied intracortical neuronal dynamics during transitions of loss of consciousness (LOC) with the α2-adrenergic agonist dexmedetomidine and return of consciousness (ROC) in a functionally interconnecting somatosensory and ventral premotor network in non-human primates. LOC, ROC and full task performance recovery were all associated with distinct neural changes. The early recovery demonstrated characteristic intermediate dynamics distinguished by sustained high spindle activities. Awakening by the α2-adrenergic antagonist completely eliminated this intermediate state and instantaneously restored awake dynamics and the top task performance while the anesthetic was still being infused. The results suggest that instantaneous functional recovery is possible following anesthetic-induced unconsciousness and the intermediate recovery state is not a necessary path for the brain recovery.
format Online
Article
Text
id pubmed-7455241
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-74552412020-08-31 Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist Ballesteros, Jesus Javier Briscoe, Jessica Blair Ishizawa, Yumiko eLife Medicine How the brain dynamics change during anesthetic-induced altered states of consciousness is not completely understood. The α2-adrenergic agonists are unique. They generate unconsciousness selectively through α2-adrenergic receptors and related circuits. We studied intracortical neuronal dynamics during transitions of loss of consciousness (LOC) with the α2-adrenergic agonist dexmedetomidine and return of consciousness (ROC) in a functionally interconnecting somatosensory and ventral premotor network in non-human primates. LOC, ROC and full task performance recovery were all associated with distinct neural changes. The early recovery demonstrated characteristic intermediate dynamics distinguished by sustained high spindle activities. Awakening by the α2-adrenergic antagonist completely eliminated this intermediate state and instantaneously restored awake dynamics and the top task performance while the anesthetic was still being infused. The results suggest that instantaneous functional recovery is possible following anesthetic-induced unconsciousness and the intermediate recovery state is not a necessary path for the brain recovery. eLife Sciences Publications, Ltd 2020-08-28 /pmc/articles/PMC7455241/ /pubmed/32857037 http://dx.doi.org/10.7554/eLife.57670 Text en © 2020, Ballesteros et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Medicine
Ballesteros, Jesus Javier
Briscoe, Jessica Blair
Ishizawa, Yumiko
Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title_full Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title_fullStr Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title_full_unstemmed Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title_short Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
title_sort neural signatures of α2-adrenergic agonist-induced unconsciousness and awakening by antagonist
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455241/
https://www.ncbi.nlm.nih.gov/pubmed/32857037
http://dx.doi.org/10.7554/eLife.57670
work_keys_str_mv AT ballesterosjesusjavier neuralsignaturesofa2adrenergicagonistinducedunconsciousnessandawakeningbyantagonist
AT briscoejessicablair neuralsignaturesofa2adrenergicagonistinducedunconsciousnessandawakeningbyantagonist
AT ishizawayumiko neuralsignaturesofa2adrenergicagonistinducedunconsciousnessandawakeningbyantagonist